Wednesday, April 6, 2016

BRIEF-Allergan reiterates termination of Pfizer transaction

* Allergan reiterates strong standalone growth profile and strategy following termination of Pfizer transaction


Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)